MODERN ASPECTS OF PROPHYLAXIS AND THERAPY FOR VENOUS THROMBO‐EMBOLIC DISEASE

This publication has 66 references indexed in Scilit:

• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism
  New England Journal of Medicine, 1997
• Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
  New England Journal of Medicine, 1997
• Comparison of the Efficacy and Safety of Low Molecular Weight Heparins and Unfractionated Heparin in the Initial Treatment of Deep Venous Thrombosis
  Drugs, 1996
• Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia – is there a risk?
  Acta Anaesthesiologica Scandinavica, 1992
• Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group
  Archives of internal medicine (1960), 1991
• Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
  New England Journal of Medicine, 1988
• A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery
  New England Journal of Medicine, 1986
• Prevention of fatal postoperative pulmonary embolism by heparin dihydroergotamine or Dextran 70
  British Journal of Surgery, 1982
• Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin
  FEBS Letters, 1976
• The separation of active and inactive forms of heparin
  Biochemical and Biophysical Research Communications, 1976